Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations

Abstract Since COVID-19 risk of reinfection is of great concern, the safety and efficacy of the mRNA-based vaccines in previously infected populations should be assessed. We studied 78 individuals previously infected with SARS-CoV-19, who received a single dose of BNT162b2 mRNA COVID-19 vaccine, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shai Efrati, Merav Catalogna, Ramzia Abu Hamad, Amir Hadanny, Adina Bar-Chaim, Patricia Benveniste-Levkovitz, Osnat Levtzion-korach
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b7488fa59c8e41a7a74b90512388b6bf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!